Literature DB >> 24009942

Changes in QT interval before and after hemodialysis.

Mohammad Reza Khosoosi Niaki1, Mehrdad Saravi, Farshid Oliaee, Roghayeh Akbari, Sepideh Noorkhomami, Seyed Hassan Bozorgi Rad, Kobra Fallahpoor, Mir Saeed Ramezani.   

Abstract

UNLABELLED: Background : Cardiovascular mortality and morbidity are high in chronic renal failure (CRF) patients. Increased dispersion of QT intervals is known to predispose to ventricular arrhythmias and sudden cardiac death. This study was conducted to assess the effect of hemodialysis (HD) on corrected QT (QTc) intervals and their dispersions (QTd) in chronic hemodialyzed patients.
METHODS: Fifty-eight patients ( mean age 54.2±15.8 years) with chronic renal disease on chronic hemodialysis (HD) were assessed by standard examination including blood pressure, body weight, heart rate, 12-lead electrocardiography and laboratory tests like electrolytes (Na (+), K (+), Ca (++), phosphate), urea, and creatinine 30 minutes before and after HD. The QT intervals and QTc QTc= QT √R-R/ (in milli seconds [ms]) for each lead were measured manually by one observer using calipers. The difference between the maximum and the minimum of QT interval was noted as QT dispersion (QT d).
RESULTS: The mean of pre and post dialysis R-R intervals was 859.22±96.85 ms and 870.43±91.45 ms, respectively (p>0.05). The mean of corrected QT cmax intervals increased significantly from 423.45±24.10 to 454.41±30.25 ms (p<0.05). The mean of QT dispersions and the corrected QT interval dispersions changed from 51.56±12.45 to 63.21±14.43 ms (p<0.05) from 59.40±13.58 to 68.33±14.55 ms (p<0.05), respectively. The changes in serum potassium and calcium levels were related with QT interval prolongation.
CONCLUSION: QT and QTc interval and dispersion increase in HD patients. Prolonged QT interval indices had relation with K(+) and Ca(++) ions before but not after HD.

Entities:  

Keywords:  Arrhythmia; Chronic renal disease; Hemodialysis; QT interval

Year:  2013        PMID: 24009942      PMCID: PMC3762231     

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


  16 in total

1.  Changes in QT intervals in patients with end-stage renal disease before and after hemodialysis.

Authors:  Mahmoud Malhis; Sami Al-Bitar; Saleh Farhood; Khair Al-Deen Zaiat
Journal:  Saudi J Kidney Dis Transpl       Date:  2010-05

2.  Determinants of augmentation of ECG QRS complexes and R waves in patients after hemodialysis.

Authors:  Abdenasser Drighil; John E Madias; Hanane El Mosalami; Nadia El Badaoui; Ahmed Bennis; Bahija Mouine; Wafae Fadili; Beenyouness Ramdani
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-04       Impact factor: 1.468

3.  Relevance of QT dispersion in haemodialysis patients.

Authors:  Biagio Di Iorio
Journal:  Nephrol Dial Transplant       Date:  2010-02-03       Impact factor: 5.992

4.  Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study.

Authors:  M Zabel; S Portnoy; M R Franz
Journal:  J Am Coll Cardiol       Date:  1995-03-01       Impact factor: 24.094

5.  Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease.

Authors:  Adrian Covic; Mirela Diaconita; Paul Gusbeth-Tatomir; Maria Covic; Adrian Botezan; Gabriel Ungureanu; David J Goldsmith
Journal:  Nephrol Dial Transplant       Date:  2002-12       Impact factor: 5.992

Review 6.  QT interval dispersion in dialysis patients.

Authors:  Vin-Cent Wu; Lian-Yu Lin; Kwan-Dun Wu
Journal:  Nephrology (Carlton)       Date:  2005-04       Impact factor: 2.506

7.  Cardiovascular death in dialysis patients: lessons we can learn from AURORA.

Authors:  Allan D Sniderman; Amirreza Solhpour; Ahsan Alam; Ken Williams; James A Sloand
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

8.  Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study.

Authors:  Hiroshi Watanabe; Toru Watanabe; Shigeru Sasaki; Kojiro Nagai; Dan M Roden; Yoshifusa Aizawa
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

9.  [QT dispersion increases during hemodialysis procedures in patients undergoing maintenance dialysis: association with an RA system and holter electrocardiogram].

Authors:  Tsuneo Murasawa; Yukinao Sakai; Saori Sakai; Tomoyuki Ohtsuka; Dai Ohno; Ken-ichi Amitani; Takuya Ono; Kazuo Munakata
Journal:  Nihon Jinzo Gakkai Shi       Date:  2008

10.  Hyperkalaemia and haemodialysis patients: eletrocardiographic changes.

Authors:  José Luis Cobo Sánchez; Ana Rosa Alconero Camarero; María Casaus Pérez; Ma Angeles Maza Sota; Camino Villa Llamazares; Carmen Hiquera Roldán; Raquel Menezo Viadero; Rosa Alonso Nates
Journal:  J Ren Care       Date:  2007 Jul-Sep
View more
  10 in total

1.  A phase 1b randomized, placebo-controlled clinical trial with SNF472 in haemodialysis patients.

Authors:  Carolina Salcedo; Pieter H Joubert; Miguel D Ferrer; Ana Z Canals; Francisco Maduell; Vicens Torregrosa; Josep Maria Campistol; Raquel Ojeda; Joan Perelló
Journal:  Br J Clin Pharmacol       Date:  2019-02-19       Impact factor: 4.335

2.  L/N-type Ca2+ channels blocker cilnidipine ameliorated the repolarization abnormality in a chronic hemodialysis patient.

Authors:  Xin Cao; Yuji Nakamura; Takeshi Wada; Hiroko Izumi-Nakaseko; Kentaro Ando; Atsushi Sugiyama
Journal:  Heart Vessels       Date:  2016-06-20       Impact factor: 2.037

3.  Monitoring of Serum Potassium and Calcium Levels in End-Stage Renal Disease Patients by ECG Depolarization Morphology Analysis.

Authors:  Hassaan A Bukhari; Carlos Sánchez; José Esteban Ruiz; Mark Potse; Pablo Laguna; Esther Pueyo
Journal:  Sensors (Basel)       Date:  2022-04-12       Impact factor: 3.847

4.  Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner.

Authors:  Jonah M Graves; Julian A Vallejo; Chelsea S Hamill; Derek Wang; Rohan Ahuja; Shaan Patel; Christian Faul; Michael J Wacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-30       Impact factor: 5.125

Review 5.  Acquired long QT syndrome in chronic kidney disease patients.

Authors:  Peng Liu; Lu Wang; Dan Han; Chaofeng Sun; Xiaolin Xue; Guoliang Li
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

6.  Association of abnormal electrocardiograph metrics with prolonged recovery time in incident hemodialysis patients.

Authors:  Jacqueline Watt; Jessica Fitzpatrick; Stephen M Sozio; Bernard G Jaar; Michelle M Estrella; Larisa G Tereshchenko; Jose M Monroy-Trujillo; Michael Walsh; Rulan S Parekh
Journal:  BMC Nephrol       Date:  2022-01-27       Impact factor: 2.388

7.  Comparison of QT Dispersion With Left Ventricular Mass Index in Early Diagnosis of Cardiac Dysfunction in Patients With β-Thalassemia Major.

Authors:  Noor Mohammad Noori; Maziar Mahjoubifard; Mehdi Mohammadi; Alireza Jahangiri Fard; Abdolhossein Abassi; Behrooz Farzanegan
Journal:  Iran Red Crescent Med J       Date:  2014-05-05       Impact factor: 0.611

8.  The effects of different electrolyte composition in dialysate on QTc interval; a controlled trial.

Authors:  Foroogh Sabzghabaei; Seyed Alireza Heydariezade; Rashin S Joodat
Journal:  J Renal Inj Prev       Date:  2016-04-06

9.  Effect of Hemodialysis on Corrected QT Interval and QTc Dispersion.

Authors:  P M Sohal; A Goel; D Gupta; N Aslam; J Sandhu; J S Sandhu; E E John; D Sharma
Journal:  Indian J Nephrol       Date:  2018 Sep-Oct

10.  The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23.

Authors:  José Alberto Navarro-García; Rafael Salguero-Bodes; Laura González-Lafuente; Laura Martín-Nunes; Elena Rodríguez-Sánchez; Teresa Bada-Bosch; Eduardo Hernández; Evangelina Mérida-Herrero; Manuel Praga; Jorge Solís; Fernando Arribas; Héctor Bueno; Makoto Kuro-O; María Fernández-Velasco; Luis Miguel Ruilope; Carmen Delgado; Gema Ruiz-Hurtado
Journal:  BMC Med       Date:  2022-01-19       Impact factor: 8.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.